Skip to main content

Table 2 Reported COVID-19 vaccine adverse events and their correlation with age and gender

From: A 1-year analysis of adverse events following COVID-19 vaccination in Lebanon: a retrospective study

AEFI

Gender

Age group (years)

Female

N = 3847 (%)

Male

N = 2509 (%)

p value

12–17

N = 233 (%)

18–44

N = 3546 (%)

45–64

N = 1864 (%)

65–74

N = 312 (%)

> 75

N = 372 (%)

p value

Systemic AEFIs

 Fatigue

1603 (41.7)

1009 (40.2)

0.251

57 (24.5)

1579 (44.5)

769 (41.3)

114 (36.5)

92 (24.7)

< 0.001*

 General body pain

1609 (41.8)

969 (38.6)

0.011*

38 (16.3)

1532 (43.2)

761 (40.8)

107 (34.3)

131 (35.2)

< 0.001*

 Headache

1482 (38.5)

859 (34.2)

0.001*

58 (24.9)

1452 (40.9)

691 (37.1)

94 (30.1)

42 (11.3)

< 0.001*

 Fever

1238 (32.2)

840 (33.5)

0.286

65 (27.9)

1,248 (35.2)

612 (32.8)

72 (23.1)

76 (20.4)

 < 0.001*

 Chills

1202 (31.2)

706 (28.1)

0.009*

31 (13.3)

1118 (31.5)

602 (32.3)

65 (20.8)

87 (23.4)

< 0.001*

 Nausea

757 (19.7)

290 (11.6)

< 0.001*

29 (12.4)

677 (19.1)

281 (15.1)

38 (12.2)

21 (5.6)

 < 0.001*

 Dyspnea

308 (8.0)

198 (7.9)

0.887

17 (7.3)

349 (9.8)

116 (6.2)

12 (3.8)

12 (3.2)

< 0.001*

 Abdominal pain

323 (8.4)

165 (6.6)

0.008*

19 (8.2)

338 (9.5)

108 (5.8)

13 (4.2)

10 (2.7)

< 0.001*

 Diarrhea

287 (7.5)

168 (6.7)

0.253

14 (6.0)

279 (7.9)

118 (6.3)

25 (8.0)

19 (5.1)

0.102

 Cough

260 (6.8)

159 (6.3)

0.535

13 (5.6)

287 (8.1)

92 (4.9)

14 (4.5)

13 (3.5)

< 0.001*

 Dizziness

240 (6.2)

134 (5.3)

0.141

41 (17.6)

220 (6.2)

85 (4.6)

18 (5.8)

10 (2.7)

< 0.001*

 Vomiting

247 (6.4)

94 (3.7)

< 0.001*

15 (6.4)

202 (5.7)

97 (5.2)

12 (3.8)

14 (3.8)

0.428

Local AEFIs

 Injection site pain

1687 (43.9)

1020 (40.7)

0.012*

63 (27.0)

1669 (47.1)

765 (41.0)

125 (40.1)

78 (21.0)

< 0.001*

 Injection site swelling

424 (11.0)

188 (7.5)

< 0.001*

17 (7.3)

380 (10.7)

177 (9.5)

26 (8.3)

10 (2.7)

< 0.001*

 Injection site erythema

296 (7.7)

113 (4.5)

< 0.001*

8 (3.4)

241 (6.8)

128 (6.9)

15 (4.8)

15 (4.0)

0.044*

  1. Results are presented as frequency (N) and percentage (%)
  2. AEFI Adverse Event Following Immunization
  3. *p < 0.05